𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: Data mining analysis

✍ Scribed by Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Akihiro Tamori; Mina Nakagawa; Namiki Izumi


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
440 KB
Volume
83
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The aim of the present study was to clarify the significance of viral factors for pretreatment prediction of sustained virological response to pegylated‐interferon (PEG‐IFN) plus ribavirin (RBV) therapy for chronic hepatitis C using data mining analysis. Substitutions in the IFN sensitivity‐determining region (ISDR) and at position 70 of the HCV core region (Core70) were determined in 505 patients with genotype 1b chronic hepatitis C treated with PEG‐IFN plus RBV. Data mining analysis was used to build a predictive model of sustained virological response in patients selected randomly (n = 304). The reproducibility of the model was validated in the remaining 201 patients. Substitutions in ISDR (odds ratio = 9.92, P < 0.0001) and Core70 (odds ratio = 1.92, P = 0.01) predicted sustained virological response independent of other covariates. The decision‐tree model revealed that the rate of sustained virological response was highest (83%) in patients with two or more substitutions in ISDR. The overall rate of sustained virological response was 44% in patients with a low number of substitutions in ISDR (0–1) but was 83% in selected subgroups of younger patients (<60 years), wild‐type sequence at Core70, and higher level of low‐density lipoprotein cholesterol (LDL‐C) (≥120 mg/dl). Reproducibility of the model was validated (r^2^ = 0.94, P < 0.001). In conclusion, substitutions in ISDR and Core70 of HCV are significant predictors of response to PEG‐IFN plus RBV therapy. A decision‐tree model that includes these viral factors as predictors could identify patients with a high probability of sustained virological response. J. Med. Virol. 83:445–452, 2011. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Hepatitis C virus and the controversial
✍ Manuela Torres-Puente; José M. Cuevas; Nuria Jiménez-Hernández; María A. Bracho; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Abstract The degree of variability of the interferon sensitivity determining region (ISDR) in the hepatitis C virus (HCV) genome has been postulated to predict the response to interferon therapy, mainly in patients infected with subtype 1b, although this prediction has been the subject of a long

Mutations in the interferon sensitivity-
✍ Kazuhiko Hayashi; Yoshiaki Katano; Takashi Honda; Masatoshi Ishigami; Akihiro It 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is thought to be inhibited by the double‐stranded RNA‐dependent protein kinase (PKR). Several studies have reported a relationship between the ISDR and interferon (IFN) responsiveness. However, this relationship is controversial. The

Pretreatment virus load and multiple ami
✍ K Chayama; A Tsubota; M Kobayashi; K Okamoto; M Hashimoto; Y Miyano; H Koike; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 3 views

biochemical and histological improvement. 3,4 Several factors Hepatitis C virus (HCV) genotype 1b and high precan predict a poor response to interferon therapy, e.g., high treatment virus load are predictive factors of poor repretreatment virus load, genotype 1b, advanced histological sponse to inte

A mutation in the interferon sensitivity
✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon